首页> 外文期刊>Immunology and allergy clinics of North America >Pharmacoeconomics of Orphan Disease Treatment with a Focus on Hereditary Angioedema
【24h】

Pharmacoeconomics of Orphan Disease Treatment with a Focus on Hereditary Angioedema

机译:孤儿病治疗的药物经济学,重点在遗传性血统血统

获取原文
获取原文并翻译 | 示例
       

摘要

This article discusses orphan diseases, their prevalence, legislative incentives to encourage development of therapies, and the impact of treatment on health care payment systems. Specifically, the cost burden of hereditary angioedema on patients, health care systems, and society is reviewed. The impact of availability of and access to novel and specific therapies on morbidity, mortality, and overall burden of disease is explored. Changes in treatment paradigms to improve effect and reduce cost of treatment are presented.
机译:本文讨论了孤儿疾病,普遍存在的疾病,立法激励措施,以鼓励发展疗法,以及治疗对医疗保健支付系统的影响。 具体而言,综述了患者,医疗保健系统和社会遗传性血统的成本负担。 探讨了可用性和获取新的和特异性疗法对发病率,死亡率和疾病的总体负担的影响。 提出了治疗范例的变化,以改善效果和降低治疗成本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号